Vanberra Signal

Breakthrough Genomics

Curated by Signal

Provider of software solution for gene testing

Overview

Breakthrough Genomics provides software for whole exome, whole genome, and gene panel tests. Its software platform ENLITER is the clinical interpretation solution that mimics the workflow of a geneticist. It also deploys a powerful free-text phenotype filter. It produces results for identifying clinically-relevant variants that are more targeted than the variant selection of top competitors. It provides tools to filter variants(ontology, HPO, phenotype terms). The software helps to check gene function and health condition.

Key facts

Founded
2016

Business model

Contact

Open roles

1 role
  • Genetic Variant Curation Scientist

    Irvine, CA · Remote · Part-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of data and computing solutions for translational and personalized medicine

    Life Sciences TechnologyCalifornia City, United States
  • Provider of biotechnology-related products and services for the agriculture sector

    Life Sciences TechnologyShirley, United States
  • Developer of a saliva test kit to detect genetic risk of various disease for clinicians and individuals

    Life Sciences TechnologyBurlingame, United States

About Breakthrough Genomics

What does Breakthrough Genomics do?

Breakthrough Genomics provides software for whole exome, whole genome, and gene panel tests.

Where is Breakthrough Genomics headquartered?

Breakthrough Genomics is headquartered in Irvine, United States.

When was Breakthrough Genomics founded?

Breakthrough Genomics was founded in 2016.

Which sector is Breakthrough Genomics in?

Breakthrough Genomics operates in Life Sciences Technology.

Who are Breakthrough Genomics's competitors?

Companies similar to Breakthrough Genomics include Bayessoft, Lifeasible, and Color.

Is Breakthrough Genomics hiring?

Yes. Breakthrough Genomics has 1 open role listed on Vanberra Signal.